Schroder Investment Management Group Allogene Therapeutics, Inc. Transaction History

Schroder Investment Management Group

  • $94.5 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 11, 2023
SELL
$4.53 - $6.74 $40,964 - $60,949
-9,043 Reduced 5.08%
168,864 $839,000
Q1 2023

May 11, 2023
SELL
$4.92 - $8.21 $62,936 - $105,022
-12,792 Reduced 6.71%
177,907 $878,000
Q4 2022

Feb 10, 2023
BUY
$5.62 - $11.11 $1.07 Million - $2.12 Million
190,699 New
190,699 $1.2 Million

Others Institutions Holding ALLO

# of Institutions
162
Shares Held
134M
Call Options Held
59.4K
Put Options Held
113K
View Full List

About Allogene Therapeutics, Inc.

ALLO Quotes by TradingView
  • Ticker ALLO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 143,807,008
  • Market Cap $326M
  • Description
  • Allogene Therapeutics, Inc., a clinical stage immuno-oncology company, develops and commercializes genetically engineered allogeneic T cell therapies for the treatment of cancer. It develops, manufactures, and commercializes UCART19, an allogeneic chimeric antigen receptor (CAR) T cell product candidate for the treatment of pediatric and adult p...
More about ALLO
Track This Portfolio

Track Schroder Investment Management Group Portfolio

Follow Schroder Investment Management Group and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Schroder Investment Management Group, based on Form 13F filings with the SEC.

News

Stay updated on Schroder Investment Management Group with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email